Learn More
  • Roy Widdus
  • 2003
There are now about 50 public–private partnerships operating internationally to provide the means of combating diseases associated with poverty. Their aim is to develop, or improve access to, health products such as drugs, vaccines, contraceptives , microbicides, diagnostics and bed-nets. Since getting under way during the last few years, they have been(More)
The global burden of disease, especially the part attributable to infectious diseases, disproportionately affects populations in developing countries. Inadequate access to pharmaceuticals plays a role in perpetuating this disparity. Drugs and vaccines may not be accessible because of weak distribution infrastructures or because development of the desired(More)
  • Roy Widdus
  • 2010
Over the past 15 years there has been a change in perceptions of what constitutes vaccine innovation to meet developing country needs. This change could reduce the global burden of infectious diseases and contribute to the ultimate achievement of many of the Millennium Development Goals. Until recently the vaccine needs of developing countries were met(More)
The reproduction of this document is regulated in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights are reserved by the Global Forum for Health Research. The report may be freely reviewed and abstracted, with the usual acknowledgement of source, but not for sale or for use in conjunction with commercial purposes.(More)
  • 1